{
  "abstract": "Jaundice affects 60% of term infants and up to 80% of preterm newborns. Early identification and treatment are necessary to prevent acute bilirubin encephalopathy and kernicterus. In October 2023, the National Institute for Health and Care Excellence (NICE) updated its clinical guideline CG98, ‘Jaundice in newborn babies under 28 days’ ( box 1). New recommendations highlighted challenges in identifying jaundice in infants with darker skin and updates regarding investigations for prolonged jaundice.",
  "authors": [
    {
      "affiliations": [
        "The London REACH Network, London, UK"
      ],
      "name": "Jasmine Innerarity"
    },
    {
      "affiliations": [
        "The London REACH Network, London, UK"
      ],
      "name": "Mailis Michaud Maturana"
    },
    {
      "affiliations": [
        "The London REACH Network, London, UK"
      ],
      "name": "Joanna Mena"
    },
    {
      "affiliations": [
        "The London REACH Network, London, UK"
      ],
      "name": "Kamla Pillay"
    },
    {
      "affiliations": [
        "The London REACH Network, London, UK"
      ],
      "name": "Eva Loucaides"
    },
    {
      "affiliations": [
        "The London REACH Network, London, UK"
      ],
      "name": "Katie Mckinnon"
    }
  ],
  "title": "Jaundice in newborn babies under 28 days: NICE guideline 2023 (CG98)",
  "uid": "173874e7-521d-5d78-9988-080790146204"
}